These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 10670640

  • 1. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K, Arima T, Yu S, Lehmann M, Flye MW.
    Transplantation; 2000 Jan 27; 69(2):285-93. PubMed ID: 10670640
    [Abstract] [Full Text] [Related]

  • 2. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T, Lehmann M, Flye MW.
    Transplantation; 1997 Jan 27; 63(2):284-92. PubMed ID: 9020332
    [Abstract] [Full Text] [Related]

  • 3. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
    Motoyama K, Arima T, Lehmann M, Flye MW.
    Surgery; 1997 Aug 27; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
    [Abstract] [Full Text] [Related]

  • 4. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW.
    J Surg Res; 2001 Jun 01; 98(1):59-65. PubMed ID: 11368539
    [Abstract] [Full Text] [Related]

  • 5. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y, Goss JA, Mohanakumar T, Flye MW.
    Transplantation; 1993 Apr 01; 55(4):877-82. PubMed ID: 8475563
    [Abstract] [Full Text] [Related]

  • 6. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA, Nakafusa Y, Yu S, Flye MW.
    Transplantation; 1993 Jul 01; 56(1):166-73. PubMed ID: 8333039
    [Abstract] [Full Text] [Related]

  • 7. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA, Yu S, Otomo N, Lehmann M, Flye MW.
    Transpl Int; 2003 Oct 01; 16(10):713-20. PubMed ID: 12827227
    [Abstract] [Full Text] [Related]

  • 8. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S, Nakafusa Y, Flye MW.
    Surgery; 1994 Aug 01; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [Abstract] [Full Text] [Related]

  • 9. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance.
    Arima T, Goss JA, Walp LA, Flye MW.
    Surgery; 1995 Aug 01; 118(2):265-72; discussion 272-3. PubMed ID: 7638743
    [Abstract] [Full Text] [Related]

  • 10. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
    Goss JA, Nakafusa Y, Flye MW.
    Ann Surg; 1992 Oct 01; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
    [Abstract] [Full Text] [Related]

  • 11. In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells.
    Yu S, Nakafusa Y, Flye MW.
    Transplantation; 1997 Dec 27; 64(12):1684-8. PubMed ID: 9422402
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK.
    Transpl Immunol; 2003 Dec 27; 12(1):41-8. PubMed ID: 14551031
    [Abstract] [Full Text] [Related]

  • 13. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA, Nakafusa Y, Flye MW.
    Ann Surg; 1993 May 27; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
    Motoyama K, Lehmann M, Flye MW.
    Transplant Proc; 1999 May 27; 31(1-2):1237-8. PubMed ID: 10083552
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB.
    Transplantation; 1993 May 27; 55(5):1112-8. PubMed ID: 8497891
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.
    Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ.
    Transplantation; 1992 Sep 27; 54(3):475-83. PubMed ID: 1384183
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.